Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

Afya (NASDAQ:AFYA) Shares Gap Down - Time to Sell?

Afya logo with Consumer Discretionary background
Image from MarketBeat Media, LLC.

Key Points

Afya Limited (NASDAQ:AFYA - Get Free Report) shares gapped down before the market opened on Monday. The stock had previously closed at $15.09, but opened at $11.71. Afya shares last traded at $12.2050, with a volume of 133,298 shares traded.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Weiss Ratings lowered shares of Afya from a "hold (c)" rating to a "hold (c-)" rating in a research note on Friday, July 31st. Wall Street Zen upgraded Afya from a "hold" rating to a "buy" rating in a research note on Saturday, September 5th. Bradesco Corretora upgraded Afya to an "outperform" rating and set a $17.00 price objective for the company in a research note on Thursday, September 24th. JPMorgan Chase & Co. raised Afya from a "neutral" rating to an "overweight" rating and reduced their target price for the company from $21.00 to $19.00 in a report on Wednesday, October 7th. Finally, Zacks Research upgraded Afya from a "strong sell" rating to a "hold" rating in a research report on Monday, October 5th. Two research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $17.25.

View Our Latest Research Report on AFYA

Afya Stock Performance

The company has a debt-to-equity ratio of 0.39, a current ratio of 2.20 and a quick ratio of 2.20. The stock has a market cap of $1.02 billion, a price-to-earnings ratio of 6.62, a PEG ratio of 1.83 and a beta of 0.34. The firm has a fifty day moving average of $13.97 and a 200 day moving average of $14.23.

Afya (NASDAQ:AFYA - Get Free Report) last issued its earnings results on Friday, August 14th. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.03. Afya had a return on equity of 17.58% and a net margin of 20.55%. The company had revenue of $187.80 million during the quarter, compared to analysts' expectations of $189.62 million. As a group, sell-side analysts forecast that Afya Limited will post 1.72 EPS for the current year.

Insider Activity

In related news, insider Santos Welder Ferreira sold 4,161 shares of the company's stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $13.30, for a total value of $55,341.30. Following the completion of the sale, the insider owned 35,000 shares of the company's stock, valued at approximately $465,500. This represents a 10.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Hedge Funds Weigh In On Afya

An institutional investor recently bought a new stake in Afya stock. Public Employees Retirement System of Ohio bought a new stake in Afya Limited (NASDAQ:AFYA - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 4,500 shares of the company's stock, valued at approximately $67,000. 88.02% of the stock is owned by institutional investors.

About Afya

(Get Free Report)

Afya Limited is a medical education and digital health company focused on Brazil. Through its educational platform, the company provides undergraduate medical education, medical residency preparation, specialization and continuing medical education programs, and other learning resources for students and physicians.

Afya also offers digital products and services intended to support healthcare professionals throughout their careers. These include clinical content, study tools, telemedicine and practice-management solutions, and subscription-based applications designed to assist physicians with education, clinical decision-making, and patient care.

The company has expanded through the development and acquisition of medical schools, education businesses, and health technology platforms serving different stages of the medical professional lifecycle.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Afya Right Now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines